Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcineurin inhibitors versus mycophenolate in pediatric steroid-resistant nephrotic syndrome
KCT0007983Phase 4Not yet recruiting
- Sponsor
- Child Cancer & Rare Disease Project
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate in nephrosis, sponsored by Child Cancer & Rare Disease Project. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
mycophenolate
03
Conditions
nephrosis
Beyond the preview
Go deeper on KCT0007983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007983.